FEED · ENvue Medical, Inc.
$0.80
-0.23 (-22.33%)
At close · Sep 16
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we do not have sufficient resources to fund our operations for the next twelve months from the date of this filing causing us to have substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$3.09M
Shares
923,718
Volume · Sep 16
125.29K
Avg daily vol (11 sessions)
199.16K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.80
Open$0.85
Day$0.66–0.99
52W close$0.80–91.80
Avg vol 30d160K
Short int7K · 0.8% float · 1.0d
Short vol18%
DataJan 2020–Sep 2026
Filing10-Q · Aug 17
Up next
filed Aug 17, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.93M
Trailing 12 months
Net income (TTM)
−$21.06M
Trailing 12 months
Revenue growth YoY
-51.6%
Year over year
Operating margin
-1,362.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-379.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1,170.7%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−96%
below
Price vs 50-day avg
−82%
below
RSI (14)
17
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−85%
trailing
6-month return
−97%
trailing
YTD return
−97%
this year
Relative strength
−112%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $18 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.79% of float · ▼ -74.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
13 holders — near 1-yr high, broad support
Fundamentals
Revenue growth
+33%
Y/Y
Gross margin
48%
contracting
EPS growth
+81%
Y/Y
Free cash flow
$-9.4M
Quant / Vol
risk profile
Volatility
201%
annualized · 1-yr
Max drawdown
−99%
past year
ATR
75.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−96%
Bearish
Price vs 50-day avg
−82%
Bearish
RSI (14)
17
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $18 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.79% of float · ▼ -74.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
13 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $92
vs 200-day avg -96%
vs 50-day avg -82%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FEED
this stock
ENvue Medical, Inc.
|
$3.09M | — | +33.1% | — | 0.8% |
|
ABT
Abbott Laboratories
|
$179.20B | -16.9% | +5.7% | 33.3 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -3.4% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -15.2% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.16B | -52.8% | +12.5% | 18.2 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
SEC Filings
Latest
8-K
- Filed
- Oct 14, 2026
- This year
- 18
ENvue Medical, Inc. entered a secured note with Alpha Capital Anstalt for up to $1,000,000, initially funded $250,000 at 10% per annum and secured by substantially all assets. It also lowered Series X conversion price to $0.50 per share.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FEED | -78.0% | -84.5% | -97.5% | -81.0% | -97.1% |
| SPY | -1.1% | -1.8% | +14.8% | -1.7% | +10.6% |
| vs SPY | -76.9% | -82.8% | -112.3% | -79.3% | -107.7% |